Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have three approved medicines that treat the underlying cause of cystic fibrosis (CF) â a rare, life-threatening genetic disease â and have several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational medicines in other serious diseases where we have deep insight into causal human biology, such as sickle cell disease, beta thalassemia, pain, alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy and APOL1-mediated kidney diseases.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America.
Source
